RATIONAL USE OF ANTIMETABOLITES OF SPECIFIC AMINO ACIDS IN COMBINATION CHEMOTHERAPY OF CANCER

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-08-024384-9.50019-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Biochemical properties and immunogenicity of L-phenylalanine ammonia-lyase: effects on tumor-bearing mice.

  1979cited by this paper
• L-cyst(e)ine requirements of malignant cells and progress toward depletion therapy.

  1979cited by this paper
• Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase.

  1979cited by this paper
• L-Threonine deaminase as a possible antitumor agent.

  1979cited by this paper
• Effects of methionine sulfoximine analogs on the synthesis of glutamine and glutathione: possible chemotherapeutic implications.

  1979cited by this paper
• In vitro system for detection of antimetabolites of specific amino acids.

  1979cited by this paper
• Proceedings of the Workshop on Amino Acid Imbalance in the Treatment of Cancer. Introduction: possibilities for biochemically rational chemotherapy for some malignancies with depleting enzymes and antimetabolites of specific amino acids.

  1979cited by this paper
• A multi-end point in vitro system for detection of new antitumor drugs.

  1978cited by this paper
• Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.

  1977cited by this paper
• Enzymes as drugs.

  1977cited by this paper
• Effects of threonine deaminase on growth and viability of mammalian cells in tissue culture and its selective cytotoxicity toward leukemia cells.

  1977cited by this paper
• Enhanced effect of L glutamine antagonist, L (αS,5S) α amino 3 chloro 4.5 dihydro 5 isoxazoleacetic acid (NSC 163501), by acinetobacter glutaminase asparaginase

  1976cited by this paper
• Bacterial glutaminase in treatment of acute leukaemia.

  1976cited by this paper
• Factors regulating growth and pigmentation of melanoma cells.

  1976cited by this paper
• Antineoplastic and toxic effects of Acinetobacter and Pseudomonas glutaminase-asparaginases.

  1974cited by this paper
• Biological effects of enzymatic deprivation of L-methionine in cell culture and an experimental tumor.

  1973cited by this paper
• U-42, 126, a New Antimetabolite Antibiotic: Production, Biological Activity, and Taxonomy of the Producing Microorganism

  1973cited by this paper
• An in Vivo Evaluation of the Chemotherapeutic Potency of Phenylalanine Ammonia-Lyase

  1973cited by this paper
• A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo.

  1973cited by this paper
• Clinical results of treatment with E. coli L‐asparaginase in adults with leukemia, lymphoma, and solid tumors

  1970cited by this paper
• Antineoplastic Activity of Highly Purified Bacterial Glutaminases

  1970cited by this paper
• Nutritional requirements of human leukemic cells. Cystine requirements of diploid cell lines and their heteroploid variants.

  1969cited by this paper
• Serine Requirement in Leukemic and Normal Blood Cells

  1969cited by this paper
• Therapy of experimental leukemias with combinations of l-asparaginase and glutamine antagonists. Abstr.

  1969cited by this paper
• Microbiological production of 5-azacytidine. I. Production and biological activity.

  1966cited by this paper
• The Effect of Arginase on the Retardation of Tumour Growth

  1965cited by this paper
• Nucleic acids components and their analogues. LI. Synthesis of 1-glycosyl derivatives of 5-azauracil and 5-azacytosine

  1964cited by this paper
• Evidence that the L-Asparaginase Activity of Guinea Pig Serum is responsible for its Antilymphoma Effects

  1961cited by this paper

• In vitro assays in preclinical antineoplastic drug screening.

  1981cites this paper